Overview
In this study investigators will add desmopressin for treatment of patients with benign prostatic hyperplasia and nocturnal polyurea
Description
Investigators will give a group of patients tamsulosin and desmopressin and the other group will take tamsulosin and placepo and compare the outcome regarding symptoms of being prostatic hyperplasia especially nocturia and the effect on nocturnal polyurea in patients
Eligibility
Inclusion Criteria:
Men with BPH Age more than 50years Patients with nocturia (2voids per night or More)
Patients with nocturnal polyurea (urine volume More than 33%of urine allover the day) IPSS
more than 12 Obstructed flow curve Post voiding residual less than 150
Exclusion Criteria:
- men with BPH with : Acute urine retention Neurogenic bladder dysfunction
Cardiovascular disease Hyponatremia Urethral stricture Bladder calculi Prostate cancer